Literature DB >> 1876520

Successful modified Fontan procedure in an adolescent after left pneumonectomy.

D Danilowicz1, A Langsner, S B Colvin.   

Abstract

We performed a Waterston's anastomosis on a patient with complicated tricuspid atresia when she was two months of age. At age 14 years she required left pneumonectomy for massive, idiopathic hemoptysis. Four months after the pneumonectomy we substituted a modified Fontan anastomosis for the Waterston anastomosis. Restudy when she was 17 years of age showed continued satisfactory function.

Entities:  

Mesh:

Year:  1991        PMID: 1876520     DOI: 10.1007/BF02238530

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  6 in total

1.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

2.  Early and intermediate-term (10-year) results of surgery for univentricular atrioventricular connection ("single ventricle").

Authors:  G Stefanelli; J W Kirklin; D C Naftel; E H Blackstone; A D Pacifico; J K Kirklin; B Soto; L M Bargeron
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

3.  Orthoterminally corrective operation in the presence of severe hypoplasia of a pulmonary artery.

Authors:  R M Sade; D A Riopel; A B Taylor
Journal:  J Thorac Cardiovasc Surg       Date:  1980-09       Impact factor: 5.209

4.  Modified Fontan operation for univentricular heart and complicated congenital lesions.

Authors:  A W Gale; G K Danielson; D C McGoon; D D Mair
Journal:  J Thorac Cardiovasc Surg       Date:  1979-12       Impact factor: 5.209

5.  Fontan procedure for tricuspid atresia.

Authors:  A W Gale; G K Danielson; D C McGoon; R B Wallace; D D Mair
Journal:  Circulation       Date:  1980-07       Impact factor: 29.690

6.  Long-term results after the Fontan operation for tricuspid atresia.

Authors:  D A Girod; F Fontan; C Deville; J Ottenkamp; A Choussat
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.